Robert C Millikan

Author PubWeight™ 142.70‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study. JAMA 2006 24.01
2 A common variant at the TERT-CLPTM1L locus is associated with estrogen receptor-negative breast cancer. Nat Genet 2011 3.37
3 Mitochondrial DNA G10398A polymorphism and invasive breast cancer in African-American women. Cancer Res 2005 3.26
4 The landscape of recombination in African Americans. Nature 2011 3.06
5 Intrinsic breast tumor subtypes, race, and long-term survival in the Carolina Breast Cancer Study. Clin Cancer Res 2010 3.04
6 A meta-analysis of genome-wide association studies of breast cancer identifies two novel susceptibility loci at 6q14 and 20q11. Hum Mol Genet 2012 2.45
7 Identification of a basal-like subtype of breast ductal carcinoma in situ. Hum Pathol 2007 2.12
8 Lifetime risk of melanoma in CDKN2A mutation carriers in a population-based sample. J Natl Cancer Inst 2005 2.10
9 Enhanced statistical tests for GWAS in admixed populations: assessment using African Americans from CARe and a Breast Cancer Consortium. PLoS Genet 2011 1.94
10 A meta-analysis identifies new loci associated with body mass index in individuals of African ancestry. Nat Genet 2013 1.82
11 Comparative analysis of breast cancer risk factors among African-American women and White women. Am J Epidemiol 2005 1.81
12 Population-based study of natural variation in the melanocortin-1 receptor gene and melanoma. Cancer Res 2006 1.80
13 A design for cancer case-control studies using only incident cases: experience with the GEM study of melanoma. Int J Epidemiol 2006 1.80
14 Number of nevi and early-life ambient UV exposure are associated with BRAF-mutant melanoma. Cancer Epidemiol Biomarkers Prev 2007 1.76
15 Physical activity and postmenopausal breast cancer: proposed biologic mechanisms and areas for future research. Cancer Epidemiol Biomarkers Prev 2009 1.67
16 FGFR2 and other loci identified in genome-wide association studies are associated with breast cancer in African-American and younger women. Carcinogenesis 2010 1.63
17 High focal adhesion kinase expression in invasive breast carcinomas is associated with an aggressive phenotype. Mod Pathol 2005 1.57
18 The prevalence of CDKN2A germ-line mutations and relative risk for cutaneous malignant melanoma: an international population-based study. Cancer Epidemiol Biomarkers Prev 2006 1.51
19 Identification, replication, and fine-mapping of Loci associated with adult height in individuals of african ancestry. PLoS Genet 2011 1.47
20 Fine-mapping of breast cancer susceptibility loci characterizes genetic risk in African Americans. Hum Mol Genet 2011 1.45
21 Ambient UV, personal sun exposure and risk of multiple primary melanomas. Cancer Causes Control 2007 1.44
22 Polymorphisms in nucleotide excision repair genes, smoking and breast cancer in African Americans and whites: a population-based case-control study. Carcinogenesis 2006 1.42
23 FAK overexpression and p53 mutations are highly correlated in human breast cancer. Int J Cancer 2009 1.35
24 CA IX is an independent prognostic marker in premenopausal breast cancer patients with one to three positive lymph nodes and a putative marker of radiation resistance. Clin Cancer Res 2006 1.35
25 Altered cytoplasmic-to-nuclear ratio of survivin is a prognostic indicator in breast cancer. Clin Cancer Res 2008 1.34
26 Increased claudin-4 expression is associated with poor prognosis and high tumour grade in breast cancer. Int J Cancer 2009 1.30
27 Reproductive factors and breast cancer risk among older women. Breast Cancer Res Treat 2006 1.30
28 Genome-wide association of body fat distribution in African ancestry populations suggests new loci. PLoS Genet 2013 1.24
29 Environmental risk factors in endemic pemphigus foliaceus (fogo selvagem). J Investig Dermatol Symp Proc 2004 1.19
30 CENP-F expression is associated with poor prognosis and chromosomal instability in patients with primary breast cancer. Int J Cancer 2007 1.17
31 Constipation, laxative use, and colon cancer in a North Carolina population. Am J Gastroenterol 2003 1.16
32 CDKN2A germline mutations in individuals with cutaneous malignant melanoma. J Invest Dermatol 2007 1.14
33 The estrogen receptor-alpha A908G (K303R) mutation occurs at a low frequency in invasive breast tumors: results from a population-based study. Breast Cancer Res 2005 1.14
34 Association of germline microRNA SNPs in pre-miRNA flanking region and breast cancer risk and survival: the Carolina Breast Cancer Study. Cancer Causes Control 2013 1.13
35 XRCC1 genotype and breast cancer: functional studies and epidemiologic data show interactions between XRCC1 codon 280 His and smoking. Cancer Res 2006 1.12
36 A genome-wide association study of breast cancer in women of African ancestry. Hum Genet 2012 1.11
37 Tandem BRAF mutations in primary invasive melanomas. J Invest Dermatol 2004 1.10
38 Trends in stage-specific incidence rates for urothelial carcinoma of the bladder in the United States: 1988 to 2006. Cancer 2013 1.07
39 Glutathione-S-transferase genotypes, smoking, and their association with markers of inflammation, hemostasis, and endothelial function: the atherosclerosis risk in communities (ARIC) study. Atherosclerosis 2003 1.06
40 Consumption of trans-fatty acid and its association with colorectal adenomas. Am J Epidemiol 2008 1.06
41 5,10-methylenetetrahydrofolate reductase 677 and 1298 polymorphisms, folate intake, and microsatellite instability in colon cancer. Cancer Epidemiol Biomarkers Prev 2005 1.05
42 UGT1A1 and UGT1A9 functional variants, meat intake, and colon cancer, among Caucasians and African-Americans. Mutat Res 2008 1.05
43 Joint effects between UDP-glucuronosyltransferase 1A7 genotype and dietary carcinogen exposure on risk of colon cancer. Cancer Epidemiol Biomarkers Prev 2005 1.04
44 Vitamin D receptor polymorphisms in patients with cutaneous melanoma. Int J Cancer 2011 1.04
45 Association between non-steroidal anti-inflammatory drugs (NSAIDs) and invasive breast cancer and carcinoma in situ of the breast. Cancer Causes Control 2003 1.04
46 μ-Opioid receptor gene A118G polymorphism predicts survival in patients with breast cancer. Anesthesiology 2012 1.03
47 Familial aggregation of melanoma risks in a large population-based sample of melanoma cases. Cancer Causes Control 2004 1.03
48 Distance to diagnosing provider as a measure of access for patients with melanoma. Arch Dermatol 2007 1.02
49 Patient perspectives on research recruitment through cancer registries. Cancer Causes Control 2005 1.02
50 Polychlorinated biphenyls, cytochrome P450 1A1 (CYP1A1) polymorphisms, and breast cancer risk among African American women and white women in North Carolina: a population-based case-control study. Breast Cancer Res 2004 1.02
51 COX-2 polymorphism, use of nonsteroidal anti-inflammatory drugs, and risk of colon cancer in African Americans (United States). Cancer Causes Control 2006 1.01
52 Urbanization and breast cancer incidence in North Carolina, 1995-1999. Ann Epidemiol 2005 1.01
53 Birthweight, parental age, birth order and breast cancer risk in African-American and white women: a population-based case-control study. Breast Cancer Res 2004 1.00
54 ADIPOQ, ADIPOR1, and ADIPOR2 polymorphisms in relation to serum adiponectin levels and BMI in black and white women. Obesity (Silver Spring) 2011 0.98
55 DNA methylation profiling in the Carolina Breast Cancer Study defines cancer subclasses differing in clinicopathologic characteristics and survival. Breast Cancer Res 2014 0.98
56 Determinants of breast cancer treatment delay differ for African American and White women. Cancer Epidemiol Biomarkers Prev 2013 0.97
57 Family history of colon cancer: what does it mean and how is it useful? Am J Prev Med 2003 0.96
58 Modification by N-acetyltransferase 1 genotype on the association between dietary heterocyclic amines and colon cancer in a multiethnic study. Mutat Res 2007 0.96
59 Mammographic density and breast cancer risk in White and African American Women. Breast Cancer Res Treat 2012 0.96
60 Risk of non-melanoma cancers in first-degree relatives of CDKN2A mutation carriers. J Natl Cancer Inst 2012 0.96
61 Vehicular Traffic-Related Polycyclic Aromatic Hydrocarbon Exposure and Breast Cancer Incidence: The Long Island Breast Cancer Study Project (LIBCSP). Environ Health Perspect 2015 0.96
62 Associations of cumulative sun exposure and phenotypic characteristics with histologic solar elastosis. Cancer Epidemiol Biomarkers Prev 2010 0.95
63 Joint effects of alcohol consumption and polymorphisms in alcohol and oxidative stress metabolism genes on risk of head and neck cancer. Cancer Epidemiol Biomarkers Prev 2011 0.95
64 Common genetic variation in adiponectin, leptin, and leptin receptor and association with breast cancer subtypes. Breast Cancer Res Treat 2011 0.95
65 Cigarette smoking, cytochrome P4501A1 polymorphisms, and breast cancer among African-American and white women. Breast Cancer Res 2004 0.93
66 Risk factors for breast cancer characterized by the estrogen receptor alpha A908G (K303R) mutation. Breast Cancer Res 2007 0.93
67 Antidepressant medications and their association with invasive breast cancer and carcinoma in situ of the breast. Epidemiology 2003 0.93
68 Use of nonsteroidal antiinflammatory drugs and risk of colon cancer in a population-based, case-control study of African Americans and Whites. Am J Epidemiol 2005 0.92
69 Selenium, folate, and colon cancer. Nutr Cancer 2009 0.90
70 MC1R genotype may modify the effect of sun exposure on melanoma risk in the GEM study. Cancer Causes Control 2010 0.90
71 GSTM1 and GSTT1 polymorphisms, cigarette smoking, and risk of colon cancer: a population-based case-control study in North Carolina (United States). Cancer Causes Control 2006 0.90
72 Breast cancer subtypes and previously established genetic risk factors: a bayesian approach. Cancer Epidemiol Biomarkers Prev 2013 0.89
73 RASSF1A and the rs2073498 Cancer Associated SNP. Front Oncol 2011 0.88
74 Genomics and the public health code of ethics. Am J Public Health 2005 0.88
75 Sun exposure, vitamin D receptor polymorphisms FokI and BsmI and risk of multiple primary melanoma. Cancer Epidemiol 2011 0.87
76 A genome-wide scan for breast cancer risk haplotypes among African American women. PLoS One 2013 0.87
77 Radiation clastogenesis and cell cycle checkpoint function as functional markers of breast cancer risk. Carcinogenesis 2006 0.87
78 Genomics and public health practice: a survey of nurses in local health departments in North Carolina. J Public Health Manag Pract 2005 0.87
79 Polymorphisms in methionine synthase, methionine synthase reductase and serine hydroxymethyltransferase, folate and alcohol intake, and colon cancer risk. J Nutrigenet Nutrigenomics 2008 0.86
80 Review of state Comprehensive Cancer Control plans for genomics content. Prev Chronic Dis 2005 0.86
81 Tumor-specific HMG-CoA reductase expression in primary premenopausal breast cancer predicts response to tamoxifen. Breast Cancer Res 2011 0.86
82 Reproductive and hormonal risk factors for ductal carcinoma in situ of the breast. Cancer Epidemiol Biomarkers Prev 2009 0.85
83 Genome-wide association study of age at menarche in African-American women. Hum Mol Genet 2013 0.85
84 Topoisomerase I amplification in melanoma is associated with more advanced tumours and poor prognosis. Pigment Cell Melanoma Res 2010 0.85
85 Selenium, apoptosis, and colorectal adenomas. Cancer Epidemiol Biomarkers Prev 2006 0.84
86 Replication of breast cancer susceptibility loci in whites and African Americans using a Bayesian approach. Am J Epidemiol 2013 0.84
87 Roles of religious involvement and social support in the risk of colon cancer among Blacks and Whites. Am J Epidemiol 2003 0.84
88 The potential for enhancing the power of genetic association studies in African Americans through the reuse of existing genotype data. PLoS Genet 2010 0.83
89 Replication of GWAS "Hits" by Race for Breast and Prostate Cancers in European Americans and African Americans. Front Genet 2011 0.83
90 Smoking and selected DNA repair gene polymorphisms in controls: systematic review and meta-analysis. Cancer Epidemiol Biomarkers Prev 2010 0.83
91 The effect of physician permission versus notification on research recruitment through cancer registries (United States). Cancer Causes Control 2006 0.82
92 Interaction of CDKN2A and sun exposure in the etiology of melanoma in the general population. J Invest Dermatol 2011 0.82
93 Associations between trans fatty acid consumption and colon cancer among Whites and African Americans in the North Carolina colon cancer study I. Nutr Cancer 2009 0.82
94 Association between mammographic density and basal-like and luminal A breast cancer subtypes. Breast Cancer Res 2013 0.81
95 Polymorphisms in DNA repair genes, recreational physical activity and breast cancer risk. Int J Cancer 2013 0.81
96 Polymorphisms in oxidative stress genes, physical activity, and breast cancer risk. Cancer Causes Control 2012 0.80
97 Microarrays and epidemiology: ensuring the impact and accessibility of research findings. Cancer Epidemiol Biomarkers Prev 2009 0.80
98 The case-only independence assumption: associations between genetic polymorphisms and smoking among controls in two population-based studies. Int J Mol Epidemiol Genet 2012 0.79
99 IGF2R genetic variants, circulating IGF2 concentrations and colon cancer risk in African Americans and Whites. Dis Markers 2012 0.79
100 Effects of polymorphisms in alcohol metabolism and oxidative stress genes on survival from head and neck cancer. Cancer Epidemiol 2013 0.77
101 trans-Fatty acid consumption and its association with distal colorectal cancer in the North Carolina Colon Cancer Study II. Cancer Causes Control 2009 0.77
102 Genetic variation in estrogen and progesterone pathway genes and breast cancer risk: an exploration of tumor subtype-specific effects. Cancer Causes Control 2014 0.77
103 Polymorphisms in the carcinogen detoxification genes CYB5A and CYB5R3 and breast cancer risk in African American women. Cancer Causes Control 2014 0.75
104 Rational Manual and Automated Scoring Thresholds for the Immunohistochemical Detection of TP53 Missense Mutations in Human Breast Carcinomas. Appl Immunohistochem Mol Morphol 2016 0.75
105 Consumption of the epidermis: a criterion in the differential diagnosis of melanoma and dysplastic nevi that is associated with increasing breslow depth and ulceration. Am J Dermatopathol 2007 0.75